Peterson Amy C. 4
4 · CytomX Therapeutics, Inc. · Filed Dec 7, 2020
Insider Transaction Report
Form 4
Peterson Amy C.
EVP, Chief Development Officer
Transactions
- Award
Common Stock
2020-11-30$6.39/sh+3,101$19,822→ 3,101 total
Footnotes (1)
- [F1]3,101 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).